Menu Search
Equities

Acacia Research Corp

AZG2:BRN

Acacia Research Corp

Actions
  • Price (CHF)4.86
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 14 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Acacia Research Corporation is focused on acquiring and managing companies across industries, including industrial, energy, technology, and healthcare verticals. Its Intellectual Property Operations segment invests in intellectual property (IP) and related absolute return assets and engages in the licensing and enforcement of patented technologies. Through its Patent Licensing, Enforcement and Technologies Business, it is a principal in the licensing and enforcement of patent portfolios, with its operating subsidiaries obtaining the rights in the patent portfolio or purchasing the patent portfolio outright. Its Industrial Operations segment is engaged in the design and manufacture of printers and consumable products for various industrial printing applications. Its Energy Operations segment includes its wells and engages in the acquisition, exploration, development, and production of oil and natural gas resources located in Roberts and Hemphill Counties in Texas.

  • Revenue in USD (TTM)165.78m
  • Net income in USD48.22m
  • Incorporated1999
  • Employees170.00
  • Location
    Acacia Research Corp767 3Rd Avenue, 6Th FloorNEW YORK 10017United StatesUSA
  • Phone+1 (949) 480-8300
  • Fax+1 (949) 480-8301
  • Websitehttps://acaciaresearch.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.